Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Teva Finland Oy
OY
Active
Y-tunnus 0658348-9
Keilaranta 10E, 02150
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1987 · 39 years old
66 employees
www.tevafinland.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Teva Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
128M
96M
64M
32M
0M
2021: 83M
83M
2021
2022: 82M (-1% vs 2021)
82M
-1%
2022
2023: 89M (+9% vs 2022)
89M
+9%
2023
2024: 98M (+10% vs 2023)
98M
+10%
2024
2025: 103M (+5% vs 2024)
103M
+5%
2025
EBITDA
EUR millions
6M
5M
3M
2M
0M
2021: 4M
4M
2021
2022: 5M (+25% vs 2021)
5M
+25%
2022
2023: 5M (0% vs 2022)
5M
0%
2023
2024: 5M (0% vs 2023)
5M
0%
2024
2025: 5M (0% vs 2024)
5M
0%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
102 740
98 452
88 963
81 854
83 071
Staff expenses
−8 592
−7 194
−7 045
−6 549
−7 501
EBITDA
5 123
4 552
4 839
4 741
4 161
Depreciation & amort.
−11
−27
−39
−58
−67
EBIT
5 112
4 524
4 800
4 683
4 095
Net financials
198
580
755
210
56
Profit before tax
5 310
5 105
5 555
4 893
4 151
Tax
1 077
1 043
1 135
1 001
856
Net profit
4 233
4 062
4 420
3 892
3 295
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
48 268
51 797
55 148
55 385
51 384
Equity
18 655
22 423
28 361
32 152
35 260
Long-term debt
1 211
1 211
0
781
1 255
Short-term debt
28 402
28 164
41 392
22 452
14 870
Total debt
29 613
29 375
26 787
23 233
16 124
Financial ratios
5-year trend
EBITDA margin
5,0 %
This company
15,8 %
Market median
This company
Market median
68% below market
2021
2025
Equity ratio
38,6 %
This company
38,2 %
Market median
This company
Market median
1% above market
2021
2025
Return on equity
22,7 %
This company
18,4 %
Market median
This company
Market median
23% above market
2021
2025
Net profit margin
4,1 %
This company
8,1 %
Market median
This company
Market median
49% below market
2021
2025
Asset turnover
2,13×
This company
1,12×
Market median
This company
Market median
90% above market
2021
2025
Debt / equity
1,59×
This company
0,62×
Market median
This company
Market median
156% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Teva Finland Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
